On Hold
LY3819253 & LY3832479 COVID-19: Clinical Study
LY3819253 & LY3832479 COVID-19: Clinical Study
Study is to measure how well LY3819253 and LY3832479 work against the virus that causes COVID-19.
Study is to measure how well LY3819253 and LY3832479 work against the virus that causes COVID-19.
Study of Ricolinostat in Patients With Diabetic Neuropathy Pain
Placebo-Controlled Study to Evaluate Efficacy and Safety of Teplizumab, in Children and Adolescents, Newly Diagnosed Type 1 Diabetes
Evaluate the Safety of Ly3209590 in Patients with type 1 diabetes being treated with multiple daily injection therapy.
Fill out the form below an we will let you know when a study becomes available that you may be interested in: